Australian researchers have demonstrated that the use of a new, less toxic drug combination after stem cell transplants for ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), and AbbVie announced today the outcome from the Phase ...

The FDA granted fast track designation to nuvisertib for those with intermediate or high-risk myelofibrosis, which ...